Publications by authors named "Marco Aguggia"

Claim this Profile
P
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Piero Barbanti, Giulia Fiorentini, Cecilia Camarda, Massimo Autunno, Francesca Pistoia, Marco Aguggia

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Second Exteroceptive Suppression Period of the Temporalis Muscle Is Altered in Migraine Patients with Allodynia.
Eugenia Rota, Paolo Immovilli, Marco Aguggia, Maria Gabriella Saracco, Elisabetta Ghiglione

Neurol Int· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d'Onofrio, Cinzia Aurilia, Marco Aguggia

Neurol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d'Onofrio, Cinzia Aurilia, Marco Aguggia

Neurol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo D'Onofrio, Marco Aguggia

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo D'Onofrio, Marco Aguggia

J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study.
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Paola Torelli, Cinzia Finocchi, Marco Aguggia

J Headache Pain· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Marco Aguggia

Eur J Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients.
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d'Onofrio, Marco Aguggia

J Headache Pain· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sport and migraine-a dynamic relationship.
Gai Annalisa, Bertuzzo Davide, Aguggia Marco

Neurol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in the second exteroceptive suppression period of the temporalis muscle during erenumab treatment.
Eugenia Rota, Marco Aguggia, Paolo Immovilli, Nicola Morelli, Davide Renosio

Naunyn Schmiedebergs Arch Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia.
Michele Tinazzi, Roberto Erro, Marcello Mario Mascia, Marcello Esposito, Tommaso Ercoli, Marco Aguggia

J Neural Transm (Vienna)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Marco Aguggia

J Headache Pain· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).
Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, Nicoletta Brunelli, Gabriella Egeo, Marco Aguggia

Neurol Sci· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acupuncture vs. Pharmacological Prophylaxis of Migraine: A Systematic Review of Randomized Controlled Trials.
Carlo Maria Giovanardi, Michela Cinquini, Marco Aguggia, Gianni Allais, Manuela Campesato

Front Neurol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia.
Michele Tinazzi, Roberto Erro, Marcello Mario Mascia, Marcello Esposito, Tommaso Ercoli, Marco Aguggia

J Neural Transm (Vienna)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry.
Francesca Di Biasio, Roberta Marchese, Giovanni Abbruzzese, Ottavia Baldi, Marcello Esposito, Marco Aguggia

Front Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia?
Giovanni Defazio, Giovanni Fabbrini, Roberto Erro, Alberto Albanese, Paolo Barone, Marco Aguggia

Parkinsonism Relat Disord· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of migraine without aura to kudzu.
Vincenzo Tullo, Marcella Curone, Bruno Colombo, Gianni Allais, Silvia Sinigaglia, Marco Aguggia

Neurol Sci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the long-term management of chronic migraine with onabotulinumtoxinA in real life.
Cristina Tassorelli, Gioacchino Tedeschi, P Sarchielli, Luigi Alberto Pini, Licia Grazzi, Marco Aguggia

Expert Rev Neurother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers.
Cristina Tassorelli, Marco Aguggia, Marina De Tommaso, Pierangelo Geppetti, Licia Grazzi

J Headache Pain· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal tyrosine metabolism in chronic cluster headache.
Giovanni D'Andrea, Massimo Leone, Gennaro Bussone, Paola Di Fiore, Andrea Bolner, Marco Aguggia

Cephalalgia· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Patent Foramen Ovale in Ischaemic Stroke in Italy: Results of SISIFO Study.
Domenico Consoli, Maurizio Paciaroni, Franco Galati, Marco Aguggia, Maurizio Melis

Cerebrovasc Dis· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P031. An observational study on chronic tension-type headache treatment with Quantum Molecular Resonance according to I.A.R.A. model.
Francesca Gulotta, Licia Grazzi, Giovanni B Allais, Sara Rolando, Maria G Saracco, Marco Aguggia

J Headache Pain· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO Study.
Domenico Consoli, Maurizio Paciaroni, Marco Aguggia, Maurizio Melis, Giovanni Malferrari

Neurol Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis